Brand  (β version)

  The number of atoms exceeds 100,000.
  So, it can not be displayed here.

Select unit:

Select hetatm:   

close
information
centroid:
interaction residue:

Select chain:   Sequence  

Data format:   

Color scheme of protein:

Ligands
Code Name Style Show Link
9GD 2-azanyl-4-[[[4-[(4-chlorophenyl)methyl-cyclopentyl-sulfamoyl]phenyl]sulfonyl-(piperidin-4-ylmethyl)amino]methyl]benzoic acid
Non-standard Residues
Code Name Show
Glycosylation
Code Name Emphasize
Modification
Code Name Show
Code : 5ML6   PDBj   RCSB PDB   PDBe
Header : LIPID BINDING PROTEIN
Title : The crystal structure of PDE6D in complex to inhibitor-8
Release Data : 2017-02-01
Compound :
mol_id molecule chains synonym
1 Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta B GMP-PDE delta,Protein p17
Source :
mol_id organism_scientific organism_common expression_system
1 Homo sapiens  (taxid:9606) Human Escherichia coli  (taxid:562)
gene: PDE6D, PDED
Authors : Fansa, E.K., Martin-gago, P., Waldmann, H., Wittinghofer, A.
Keywords : Prenyl binding protein, farnesylated KRas, Plasma membrane, Arl2, Lipid binding protein
Exp. method : X-RAY DIFFRACTION ( 1.8700 Å )
Citation :

A PDE6 delta-KRas Inhibitor Chemotype with up to Seven H-Bonds and Picomolar Affinity that Prevents Efficient Inhibitor Release by Arl2.

Martin-Gago, P.,Fansa, E.K.,Klein, C.H.  et al.
(2017)  Angew. Chem. Int. Ed. Engl.  56 : 2423 - 2428

PubMed: 28106325
DOI: 10.1002/anie.201610957

Chain : B
UniProt : O43924 (PDE6D_HUMAN)
Reaction : -